The role of growth hormone and insulin-like growth factor I in oxidative processes;Rola hormonu wzrostu i insulinopodobnego czynnika wzrostu I w procesach oksydacyjnych

Endokrynologia Polska

Volumn 59, Issue 6, 2008, Pages 496-501

  Kokoszko, Agnieszka ^a,b   Lewiński, Andrzej ^a,b   Karbownik Lewińska, Małgorzata ^a,b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Acromegaly; Growth hormone; Growth hormone deficiency; Insulin like growth factor I; Lipid peroxidation; Oxidative stress

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SYNTHESIS; HUMAN; LIPID PEROXIDATION; METABOLIC BALANCE; MOLECULAR INTERACTION; OXIDATIVE STRESS; REVIEW;

ANIMALS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; OXIDATION-REDUCTION; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 60049088670     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Halhwell B, Gutteridge JMC. Free radicals in biology and medicine. Wyd. 3. Oxford University Press, Oxford 1999.
2. Valko M, Leibfritz D, Moncol J i wsp. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84.
3. Bartosz G. Druga twarz tlenu. Wydawnictwo Naukowe PWN, Warszawa 2006.
4. Valko M, Rhodes CJ, Moncol J i wsp. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006; 160: 1-40.
5. Brown-Borg HM, Rakoczy SG, Romanick MA i wsp. Effects of growth hormone and insulin-like growth factor-I on hepatocyte antioxidative enzymes. Exp Biol Med 2002; 227: 94-104.
6. Thum T, Tsikas D, Frolich JC i wsp. Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett 2003; 555: 567-571.
7. O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res 2001; 88: 12-21.
8. Brown-Borg HM, Rakoczy SG. Catalse expression in delayed and premature aging mouse models. Exp Gerontol 2000; 35: 199-212.
9. Brown-Borg HM, Rakoczy SG. Growth hormone administration to long-living dwarf mice alters multiple components of the antioxidative defense system. Mech Ageing Dev 2003; 124: 1013-1024.
10. Hauck SJ, Bartke A. Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality. J Gerontol 2001; 56A: B153-B162.
11. Youn YK, Suh GJ, Jung SE i wsp. Recombinant human growth hormone decreases lung and liver tissue lipid peroxidation and increases antioxidant activity after thermal injury in rats. J Burn Care Rehabil 1998; 19: 54-548.
12. Kireev RA, Tresguerres ACF, Castillo C i wsp. Effect of exogenous administration of melatonin and growth hormone on pro-antioxidant functions of the liver in aging male rats. J Pineal Res 2007; 42: 64-70.
13. Castilla-Cortazar I, Garcia M, Muguerza B i wsp. Hepatoprotective effects of insulin-like growth factor-I in rats with carbon tetrachloride-induced cirrhosis. Gastroenterology 1997; 113: 1682-1691.
14. Garcia-Fernandez M, Castilla-Cortazar I, Diaz-Sanchez M i wsp. Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. BMC Gastroenterol 2005; 5: 7.
15. Chen S, Wang H-T, Yang B i wsp. Protective effects of recombinant human growth hormone on cirrhotic rats. World J Gastroenterol 2004; 10: 2894-2897.
16. Huang Y, Wang S-R, Yi C i wsp. Effects of recombinant human growth hormone on rat septic shock with intraabdominal infection by E. coli. World J Gastroenterol 2002; 8: 1134-1137.
17. Jung SE, Youn YK, Lim YS i wsp. Combined administration of glutamine and growth hormone synergistically reduces bacterial translocation in sepsis. J Korean Med Sci 2003; 18: 17-22.
18. Kokoszko A, Dabrowski J, Lewiński A i wsp. Protective effects of GH and IGF-I against iron-induced lipid peroxidation in vivo. Exp Toxicol Pathol 2008; 60: 453-458.
19. Guney Y, Hicsonmez A, Uluoglu C i wsp. Melatonin prevents inflammation and oxidative stress caused by abdominopelvic and total body irradiation of rat small intestine. Braz J Med Biol Res 2007; 40: 1305-1314.
20. Sener G, Jahovic N, Tosun O i wsp. Melatonin ameliorates ionizing radiation-induced oxidative organ damage in rats. Life Sci 2003; 74: 563-572.
21. Bhor VM, Raghuram N, Sivakami S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin-induced diabetic rats. Int J Biochem Cell Biol 2004; 36: 89-97.
22. Shirpoor A, Khadem Ansari MH, Salami S i wsp. Effect of vitamin E on oxidative stress status in small intestine of diabetic rat. World J Gastroenterol 2007; 13: 4340-4344.
23. Halliwell B, Zhao K, Whiteman M. The gastrointestinal tract: a major site of antioxidant action? Free Radic Res 2000; 33: 819-830.
24. Prabhu R, Anup R, Balasubramanian KA. Surgical stress induces phospholipid degradation in the intestinal brush order membrane. J Surg Res 2000; 94: 178-184.
25. Karbownik-Lewińska M, Kokoszko A, Józefiak M i wsp. Significance of increased lipid peroxidation in critically ill patients. Neuroendocrinol Lett 2007; 28: 367-381.
26. Takala J, Ruokonen E, Webster NR i wsp. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999; 341: 785-792.
27. Hankinson SE, Willett WC, Colditz GA i wsp. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-1396.
28. Kurek R, Tunn UW, Eckart O i wsp. The significance of serum levels of insulin-like growth factor-I in patients with prostate cancer. BJU Int 2000; 85: 125-129.
29. Elsasser TH, Kahl S, MacLeod C i wsp. Mechanisms underlying growth hormone effects in augmenting nitric oxide production and protein tyrosine nitration during endotoxin challenge. Endocrinology 2004; 145: 3413-3423.
30. Andersson IJ, Johansson ME, Wickman A i wsp. Endothelial dysfunction in growth hormone transgenic mice. Clin Sci 2006, 110: 217-225.
31. Kokoszko A, Karbownik M, Lewiński A. Increased lipid peroxidation in growth hormone-deficient adult patients. Neuroendocrinol Lett 2006; 27: 225-230.
32. Ozbey N, Telci A, Cakatay U i wsp. Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency. J Endocrinol Invest 2003; 26: 1001-1007.
33. Evans LM, Davies JS, Anderson RA i wsp. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency. Eur J Endocrinol 2000; 142: 254-262.
34. Scacchi M, Valassi E, Pincelli AT i wsp. Increased lipid peroxidation in adult GH-deficient patients: effects of short-term GH administration. J Endocrinol Invest 2006; 29: 899-904.
35. Takahashi Y, Iida K, Takahashi K i wsp. Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency. Gastroenterology 2007; 132: 938-943.
36. Karbownik-Lewińska M, Kokoszko A, Lewandowski KC i wsp. Growth hormone replacement reduces increased lipid peroxidation in growth hormone-deficient adults. Clin Endocrinol (Oxf) 2008; 68: 957-964.
37. Mohn A, Di Marzio D, Giannini C i wsp. Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy. Clin Endocrinol 2005; 63: 537-542.
38. Yarman S, Özden TA, Gökkuşu C. The evaluation of lipid peroxidation and acute effect of octreotide on lipid peroxidation in patients with active acromegaly. Clin Chim Acta 2003; 336: 45-48.